Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium

NCT: NCT07594483 · NOT_YET_RECRUITING

NCT IDNCT07594483
StatusNOT_YET_RECRUITING
Start Date2026-05
Completion2027-12

Brief Summary

The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System when used as indicated for treatment-resistant depression (TRD).

Frequently Asked Questions

What is Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium?

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium is a clinical trial registered under NCT07594483. Current status: NOT_YET_RECRUITING.

What is the status of NCT07594483?

The current status of NCT07594483 (Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium) is: NOT_YET_RECRUITING.

When did Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium start?

Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium started on 2026-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑